Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nurix Therapeutics

11.49
-0.1300-1.12%
Post-market: 11.490.00000.00%17:10 EDT
Volume:1.48M
Turnover:17.04M
Market Cap:875.95M
PE:-4.10
High:11.88
Open:11.73
Low:11.22
Close:11.62
Loading ...

Nurix Therapeutics price target raised to $36 from $34 at Stifel

TIPRANKS
·
29 Jan

RBC Raises Price Target on Nurix Therapeutics to $27 From $26, Keeps Outperform, Speculative Risk

MT Newswires Live
·
29 Jan

Nurix Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
29 Jan

Nurix Therapeutics Inc : Stifel Raises Target Price to $36 From $34

THOMSON REUTERS
·
29 Jan

Positive Outlook for Nurix Therapeutics with Buy Rating Supported by Promising Clinical Activity and Strong Financial Position

TIPRANKS
·
29 Jan

Buy Rating for Nurix Therapeutics: Strong Cash Position and Upcoming Catalysts Justify $36 Price Target Despite Wider Net Loss

TIPRANKS
·
29 Jan

Nurix Therapeutics price target raised to $36 from $35 at H.C. Wainwright

TIPRANKS
·
29 Jan

Nurix Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $36 From $35

THOMSON REUTERS
·
29 Jan

Oppenheimer Reaffirms Their Buy Rating on Nurix Therapeutics (NRIX)

TIPRANKS
·
29 Jan

Nurix Therapeutics, Inc. (NRIX) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
29 Jan

Nurix Therapeutics Fiscal Q4 Net Loss Narrows, Revenue Falls

MT Newswires Live
·
29 Jan

Nurix Therapeutics Q4 EPS $(0.75) Misses $(0.68) Estimate, Sales $13.28M Beat $12.86M Estimate

Benzinga
·
29 Jan

Nurix Therapeutics Announces Appointment of John Northcott as Chief Commercial Officer

THOMSON REUTERS
·
22 Jan

Nurix Therapeutics Price Target Maintained With a $31.00/Share by Stephens & Co.

Dow Jones
·
22 Jan

We Think Nurix Therapeutics (NASDAQ:NRIX) Can Afford To Drive Business Growth

Simply Wall St.
·
19 Jan

Barclays Reaffirms Their Buy Rating on Nurix Therapeutics (NRIX)

TIPRANKS
·
15 Jan

Truist Financial Reaffirms Their Buy Rating on Nurix Therapeutics (NRIX)

TIPRANKS
·
14 Jan

Strength Seen in SpringWorks Therapeutics (SWTX): Can Its 6.0% Jump Turn into More Strength?

Zacks
·
08 Jan

Nurix Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire
·
06 Jan

Nurix Therapeutics Says Waldenstrom Macroglobulinemia Drug Granted Fast Track Designation by FDA

MT Newswires Live
·
19 Dec 2024